Product Information
ARISTADA ER 662 MG/2.4 ML SYRN is a brand product labeled by Alkermes, Inc., priced at $1005.8851 per ML under NDC 65757040203. Its NADAC has been published 506 times since Oct 19, 2016.
Strength
662 mg/2.4mL
Manufacturer
Alkermes, Inc.NDC
65757040203
Classification
Brand
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLE LAUROXILApproval Type
New Drug (NDA)
FDA Application
NDA207533On Market Since
10/5/2015
Pharmacological Classes
Price Statistics
The NADAC for ARISTADA ER 662 MG/2.4 ML SYRN has been published 506 times since Oct 19, 2016, and over the history we have for it it has risen 53.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1005.8851 per ML |
|---|---|
| All-time high | $1005.8851 (Jun 24, 2026) |
| All-time low | $655.3550 (Oct 19, 2016) |
| 52-week high | $1005.8851 |
| 52-week low | $942.9156 |
| Median price | $845.4223 |
| Average price | $829.9030 |
| Largest weekly change | +6.0% (Apr 15, 2020) |
| Weeks tracked | 506 |
| Tracking since | Oct 19, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the aripiprazole lauroxil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARISTADA ER 662 MG/2.4 ML SYRN?
The current National Average Drug Acquisition Cost (NADAC) for ARISTADA ER 662 MG/2.4 ML SYRN, manufactured by Alkermes, Inc., is $1005.8851 per ML (NDC 65757040203), effective Jun 24, 2026.
How has the price of ARISTADA ER 662 MG/2.4 ML SYRN changed over time?
Over the history we have for it, the NADAC for ARISTADA ER 662 MG/2.4 ML SYRN has risen 53.5%. It has been tracked across 506 weekly CMS publications since Oct 19, 2016.
What are the highest and lowest recorded NADAC prices for ARISTADA ER 662 MG/2.4 ML SYRN?
Since Oct 19, 2016, the NADAC for ARISTADA ER 662 MG/2.4 ML SYRN has ranged from a low of $655.3550 (Oct 19, 2016) to a high of $1005.8851 (Jun 24, 2026), with a median of $845.4223 per ML.
Are there cheaper alternatives to ARISTADA ER 662 MG/2.4 ML SYRN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARISTADA ER 662 MG/2.4 ML SYRN, so no direct lower-cost alternative is listed.
Who manufactures ARISTADA ER 662 MG/2.4 ML SYRN?
ARISTADA ER 662 MG/2.4 ML SYRN (NDC 65757040203) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification